ArticleRadiology. Cardiothoracic imaging2021
Diagnostic Performance of CO-RADS and the RSNA Classification System in Evaluating COVID-19 at Chest CT: A Meta-Analysis.
Article in Radiology. Cardiothoracic imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Diagnostic performance of CO-RADS for COVID-19: a systematic review and meta-analysis.European radiology · 2022Pooled it
- Diagnostic value of chest computed tomography imaging for COVID-19 based on reverse transcription-polymerase chain reaction: a meta-analysis.Infectious diseases of poverty · 2021Pooled it
- Agreement between emergency medicine residents and radiologists in RSNA-Based chest CT interpretation.Emergency radiology · 2026Article
- Improved kidney function is associated with Colchicine treatment in COVID-19 patients.BMC nephrology · 2024Article
- Reply to the Letter to the Editor Titled "Neuroimaging Abnormalities in SARS-CoV-2 Infected are More Diverse than Previously Thought and Depend on the Methods Used".The Indian journal of radiology & imaging · 2024Article
- Associated Factors and Outcomes of Acute Kidney Injury in COVID-19 Patients in Kenya.Canadian journal of kidney health and disease · 2024Article
- Inter-observer Variability in the Analysis of CO-RADS Classification for COVID-19 Patients.Tropical medicine and infectious disease · 2023Article
- Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes.BMC pulmonary medicine · 2023Article
- COVID-19 progression in hospitalized patients using follow-upJournal of thoracic disease · 2023Article
- Diagnostic performance of standardized typical CT findings for COVID-19: a systematic review and meta-analysis.Insights into imaging · 2023Article
- Relation between Cytokine Levels and Pulmonary Dysfunction in COVID-19 Patients: A Case-Control Study.Journal of personalized medicine · 2022Article
- The Additional Value of Lower Respiratory Tract Sampling in the Diagnosis of COVID-19: A Real-Life Observational Study.Diagnostics (Basel, Switzerland) · 2022Article
- COVID-19 in the Radiology Literature: A Look Back.Radiology. Cardiothoracic imaging · 2022Article
- Diagnostic accuracy of CO-RADS in patients with suspected Coronavirus Disease-2019: A single center experience.Clinical imaging · 2022Article
- A Deep Learning Approach to Identify Chest Computed Tomography Features for Prediction of SARS-CoV-2 Infection Outcomes.Methods in molecular biology (Clifton, N.J.) · 2022Article
- The role of chest imaging in the diagnosis, management, and monitoring of coronavirus disease 2019 (COVID-19).Insights into imaging · 2021Review
- Imaging of COVID-19: An update of current evidences.Diagnostic and interventional imaging · 2021Review
- Emerging Pulmonary Infections in Clinical Practice.Advances in clinical radiology · 2021Review
- Comparison of the CO-RADS and the RSNA chest CT classification system concerning sensitivity and reliability for the diagnosis of COVID-19 pneumonia.Insights into imaging · 2021Article
- Diagnostic performance of the RSNA-proposed classification for COVID-19 pneumonia versus pre-pandemic controls.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious DiseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the diagnostic performance of the COVID-19 Reporting and Data System (CO-RADS) and the Radiological Society of North America (RSNA) categorizations in patients with clinically suspected coronavirus disease 2019 (COVID-19) infection. MATERIALS AND
methodsIn this meta-analysis, studies from 2020, up to August 24, 2020 were assessed for inclusion criteria of studies that used CO-RADS or the RSNA categories for scoring chest CT in patients with suspected COVID-19. A total of 186 studies were identified. After review of abstracts and text, a total of nine studies were included in this study. Patient information (
resultsNine studies (3283 patients) were included. Overall study quality was good, except for risk of non-performance of repeated reverse transcriptase polymerase chain reaction (RT-PCR) after negative initial RT-PCR and persistent clinical suspicion in four studies. Pooled COVID-19 frequencies in CO-RADS categories were: 1, 8.8%; 2, 11.1%; 3, 24.6%; 4, 61.9%; and 5, 89.6%. Pooled COVID-19 frequencies in RSNA classification categories were: negative 14.4%; atypical, 5.7%; indeterminate, 44.9%; and typical, 92.5%. Pooled pairs of sensitivity and specificity using CO-RADS thresholds were the following: at least 3, 92.5% (95% CI: 87.1, 95.7) and 69.2% (95%: CI: 60.8, 76.4); at least 4, 85.8% (95% CI: 78.7, 90.9) and 84.6% (95% CI: 79.5, 88.5); and 5, 70.4% (95% CI: 60.2, 78.9) and 93.1% (95% CI: 87.7, 96.2). Pooled pairs of sensitivity and specificity using RSNA classification thresholds for indeterminate were 90.2% (95% CI: 87.5, 92.3) and 75.1% (95% CI: 68.9, 80.4) and for typical were 65.2% (95% CI: 37.0, 85.7) and 94.9% (95% CI: 86.4, 98.2).
conclusionCOVID-19 infection frequency was higher in patients categorized with higher CORADS and RSNA classification categories.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.